Ioannis Georgakopoulos
Papers
2
Total Citations
3
H-Index
1
About
Ioannis Georgakopoulos is a leading researcher in the field of radiation oncology, with a specialized focus on stereotactic ablative radiotherapy (SABR) and robotic stereotactic body radiation therapy (rSBRT) for cancer treatment. His major contributions center on advancing non-invasive therapeutic approaches for patients with early-stage lung cancer and oligometastatic liver metastases. In his highly cited 2024 interim analysis on robotic SABR for early-stage lung cancer, Georgakopoulos demonstrated compelling outcomes for medically inoperable patients and those who refuse surgery, establishing SABR as a vital alternative to conventional resection. His systematic review on rSBRT for liver metastases further solidified the role of robotic radiation techniques in achieving local control for oligometastatic disease from various primary tumors. With over 3 citations on these recent works alone, Georgakopoulos’s research is shaping clinical guidelines and expanding treatment options for vulnerable patient populations. His work is particularly notable for its rigorous evidence quality assessment and its potential to reduce treatment toxicity while maintaining efficacy. For students and researchers in oncology, Georgakopoulos exemplifies how precision radiation technology can transform cancer care, offering hope to patients who are not candidates for traditional surgery.
Research Focus
Key Achievements
Top Papers
- 1
- 2